Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway

Tom Nijenhuis, Alexis J. Sloan, Joost G J Hoenderop, Jan Flesche, Harry Van Goor, Andreas D. Kistler, Marinka Bakker, Rene J M Bindels, Rudolf A. De Boer, Clemens C. Möller, Inge Hamming, Gerjan Navis, Jack F M Wetzels, Jo H M Berden, Jochen Reiser, Christian H Faul, Johan Van Der Vlag

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

The transient receptor potential channel C6 (TRPC6) is a slit diaphragmassociated protein in podocytes involved in regulating glomerular filter function. Gain-of-function mutations in TRPC6 cause hereditary focal segmental glomerulosclerosis (FSGS), and several human acquired proteinuric diseases show increased glomerular TRPC6 expression. Angiotensin II (AngII) is a key contributor to glomerular disease and may regulate TRPC6 expression in nonrenal cells. We demonstrate that AngII regulates TRPC6 mRNA and protein levels in cultured podocytes and that AngII infusion enhances glomerular TRPC6 expression in vivo. In animal models for human FSGS (doxorubicin nephropathy) and increased renin-angiotensin system activity (Ren2 transgenic rats), glomerular TRPC6 expression was increased in an AngII-dependent manner. TRPC6 expression correlated with glomerular damage markers and glomerulosclerosis. We show that the regulation of TRPC6 expression by AngII and doxorubicin requires TRPC6-mediated Ca 2+ influx and the activation of the Ca 2+-dependent protein phosphatase calcineurin and its substrate nuclear factor of activated T cells (NFAT). Accordingly, calcineurin inhibition by cyclosporine decreased TRPC6 expression and reduced proteinuria in doxorubicin nephropathy, whereas podocyte-specific inducible expression of a constitutively active NFAT mutant increased TRPC6 expression and induced severe proteinuria. Our findings demonstrate that the deleterious effects of AngII on podocytes and its pathogenic role in glomerular disease involve enhanced TRPC6 expression via a calcineurin/NFAT positive feedback signaling pathway.

Original languageEnglish
Pages (from-to)1719-1732
Number of pages14
JournalAmerican Journal of Pathology
Volume179
Issue number4
DOIs
StatePublished - Oct 1 2011
Externally publishedYes

Fingerprint

NFATC Transcription Factors
Transient Receptor Potential Channels
Podocytes
Angiotensin II
Wounds and Injuries
Calcineurin
Doxorubicin
Focal Segmental Glomerulosclerosis
Proteinuria
Transgenic Rats
Protein Phosphatase 2
Renin-Angiotensin System
Cyclosporine

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Nijenhuis, T., Sloan, A. J., Hoenderop, J. G. J., Flesche, J., Van Goor, H., Kistler, A. D., ... Van Der Vlag, J. (2011). Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. American Journal of Pathology, 179(4), 1719-1732. https://doi.org/10.1016/j.ajpath.2011.06.033

Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. / Nijenhuis, Tom; Sloan, Alexis J.; Hoenderop, Joost G J; Flesche, Jan; Van Goor, Harry; Kistler, Andreas D.; Bakker, Marinka; Bindels, Rene J M; De Boer, Rudolf A.; Möller, Clemens C.; Hamming, Inge; Navis, Gerjan; Wetzels, Jack F M; Berden, Jo H M; Reiser, Jochen; Faul, Christian H; Van Der Vlag, Johan.

In: American Journal of Pathology, Vol. 179, No. 4, 01.10.2011, p. 1719-1732.

Research output: Contribution to journalArticle

Nijenhuis, T, Sloan, AJ, Hoenderop, JGJ, Flesche, J, Van Goor, H, Kistler, AD, Bakker, M, Bindels, RJM, De Boer, RA, Möller, CC, Hamming, I, Navis, G, Wetzels, JFM, Berden, JHM, Reiser, J, Faul, CH & Van Der Vlag, J 2011, 'Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway', American Journal of Pathology, vol. 179, no. 4, pp. 1719-1732. https://doi.org/10.1016/j.ajpath.2011.06.033
Nijenhuis, Tom ; Sloan, Alexis J. ; Hoenderop, Joost G J ; Flesche, Jan ; Van Goor, Harry ; Kistler, Andreas D. ; Bakker, Marinka ; Bindels, Rene J M ; De Boer, Rudolf A. ; Möller, Clemens C. ; Hamming, Inge ; Navis, Gerjan ; Wetzels, Jack F M ; Berden, Jo H M ; Reiser, Jochen ; Faul, Christian H ; Van Der Vlag, Johan. / Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. In: American Journal of Pathology. 2011 ; Vol. 179, No. 4. pp. 1719-1732.
@article{3c836ce4d0284a0ebef03d0eac1c47c4,
title = "Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway",
abstract = "The transient receptor potential channel C6 (TRPC6) is a slit diaphragmassociated protein in podocytes involved in regulating glomerular filter function. Gain-of-function mutations in TRPC6 cause hereditary focal segmental glomerulosclerosis (FSGS), and several human acquired proteinuric diseases show increased glomerular TRPC6 expression. Angiotensin II (AngII) is a key contributor to glomerular disease and may regulate TRPC6 expression in nonrenal cells. We demonstrate that AngII regulates TRPC6 mRNA and protein levels in cultured podocytes and that AngII infusion enhances glomerular TRPC6 expression in vivo. In animal models for human FSGS (doxorubicin nephropathy) and increased renin-angiotensin system activity (Ren2 transgenic rats), glomerular TRPC6 expression was increased in an AngII-dependent manner. TRPC6 expression correlated with glomerular damage markers and glomerulosclerosis. We show that the regulation of TRPC6 expression by AngII and doxorubicin requires TRPC6-mediated Ca 2+ influx and the activation of the Ca 2+-dependent protein phosphatase calcineurin and its substrate nuclear factor of activated T cells (NFAT). Accordingly, calcineurin inhibition by cyclosporine decreased TRPC6 expression and reduced proteinuria in doxorubicin nephropathy, whereas podocyte-specific inducible expression of a constitutively active NFAT mutant increased TRPC6 expression and induced severe proteinuria. Our findings demonstrate that the deleterious effects of AngII on podocytes and its pathogenic role in glomerular disease involve enhanced TRPC6 expression via a calcineurin/NFAT positive feedback signaling pathway.",
author = "Tom Nijenhuis and Sloan, {Alexis J.} and Hoenderop, {Joost G J} and Jan Flesche and {Van Goor}, Harry and Kistler, {Andreas D.} and Marinka Bakker and Bindels, {Rene J M} and {De Boer}, {Rudolf A.} and M{\"o}ller, {Clemens C.} and Inge Hamming and Gerjan Navis and Wetzels, {Jack F M} and Berden, {Jo H M} and Jochen Reiser and Faul, {Christian H} and {Van Der Vlag}, Johan",
year = "2011",
month = "10",
day = "1",
doi = "10.1016/j.ajpath.2011.06.033",
language = "English",
volume = "179",
pages = "1719--1732",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway

AU - Nijenhuis, Tom

AU - Sloan, Alexis J.

AU - Hoenderop, Joost G J

AU - Flesche, Jan

AU - Van Goor, Harry

AU - Kistler, Andreas D.

AU - Bakker, Marinka

AU - Bindels, Rene J M

AU - De Boer, Rudolf A.

AU - Möller, Clemens C.

AU - Hamming, Inge

AU - Navis, Gerjan

AU - Wetzels, Jack F M

AU - Berden, Jo H M

AU - Reiser, Jochen

AU - Faul, Christian H

AU - Van Der Vlag, Johan

PY - 2011/10/1

Y1 - 2011/10/1

N2 - The transient receptor potential channel C6 (TRPC6) is a slit diaphragmassociated protein in podocytes involved in regulating glomerular filter function. Gain-of-function mutations in TRPC6 cause hereditary focal segmental glomerulosclerosis (FSGS), and several human acquired proteinuric diseases show increased glomerular TRPC6 expression. Angiotensin II (AngII) is a key contributor to glomerular disease and may regulate TRPC6 expression in nonrenal cells. We demonstrate that AngII regulates TRPC6 mRNA and protein levels in cultured podocytes and that AngII infusion enhances glomerular TRPC6 expression in vivo. In animal models for human FSGS (doxorubicin nephropathy) and increased renin-angiotensin system activity (Ren2 transgenic rats), glomerular TRPC6 expression was increased in an AngII-dependent manner. TRPC6 expression correlated with glomerular damage markers and glomerulosclerosis. We show that the regulation of TRPC6 expression by AngII and doxorubicin requires TRPC6-mediated Ca 2+ influx and the activation of the Ca 2+-dependent protein phosphatase calcineurin and its substrate nuclear factor of activated T cells (NFAT). Accordingly, calcineurin inhibition by cyclosporine decreased TRPC6 expression and reduced proteinuria in doxorubicin nephropathy, whereas podocyte-specific inducible expression of a constitutively active NFAT mutant increased TRPC6 expression and induced severe proteinuria. Our findings demonstrate that the deleterious effects of AngII on podocytes and its pathogenic role in glomerular disease involve enhanced TRPC6 expression via a calcineurin/NFAT positive feedback signaling pathway.

AB - The transient receptor potential channel C6 (TRPC6) is a slit diaphragmassociated protein in podocytes involved in regulating glomerular filter function. Gain-of-function mutations in TRPC6 cause hereditary focal segmental glomerulosclerosis (FSGS), and several human acquired proteinuric diseases show increased glomerular TRPC6 expression. Angiotensin II (AngII) is a key contributor to glomerular disease and may regulate TRPC6 expression in nonrenal cells. We demonstrate that AngII regulates TRPC6 mRNA and protein levels in cultured podocytes and that AngII infusion enhances glomerular TRPC6 expression in vivo. In animal models for human FSGS (doxorubicin nephropathy) and increased renin-angiotensin system activity (Ren2 transgenic rats), glomerular TRPC6 expression was increased in an AngII-dependent manner. TRPC6 expression correlated with glomerular damage markers and glomerulosclerosis. We show that the regulation of TRPC6 expression by AngII and doxorubicin requires TRPC6-mediated Ca 2+ influx and the activation of the Ca 2+-dependent protein phosphatase calcineurin and its substrate nuclear factor of activated T cells (NFAT). Accordingly, calcineurin inhibition by cyclosporine decreased TRPC6 expression and reduced proteinuria in doxorubicin nephropathy, whereas podocyte-specific inducible expression of a constitutively active NFAT mutant increased TRPC6 expression and induced severe proteinuria. Our findings demonstrate that the deleterious effects of AngII on podocytes and its pathogenic role in glomerular disease involve enhanced TRPC6 expression via a calcineurin/NFAT positive feedback signaling pathway.

UR - http://www.scopus.com/inward/record.url?scp=80053282316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053282316&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2011.06.033

DO - 10.1016/j.ajpath.2011.06.033

M3 - Article

VL - 179

SP - 1719

EP - 1732

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 4

ER -